A groundbreaking new diagnostic technique has the potential to revolutionize how microbial infections are identified, cutting the time required from days to just 20 minutes. Researchers say the rapid method could significantly improve patient outcomes, enable earlier and more targeted treatment, and play a crucial role in combating the growing global threat of antibiotic resistance. Traditional infection diagnosis often involves culturing samples in a lab, a process that can take several days. This delay can lead to the overuse of broad-spectrum antibiotics while waiting for results, which in turn accelerates the development of drug-resistant bacteria. The new system, developed by a team of scientists, uses advanced biosensors and machine learning to detect specific pathogens and their resistance profiles almost immediately. The technology works by analyzing minute biological signals in a patient’s sample—such as changes in electrical conductivity or molecular markers—allowing it to identify the type of infection and whether the pathogen is resistant to common antibiotics. Early tests have shown high accuracy across a range of common infections, including urinary tract infections, bloodstream infections, and respiratory illnesses. By providing results in under 20 minutes, the system enables clinicians to make informed treatment decisions in real time. This means patients can receive the right antibiotic from the start, reducing the need for trial-and-error prescribing and minimizing the risk of resistance development. Experts believe this innovation could be especially valuable in hospitals, emergency rooms, and low-resource settings where rapid diagnosis is critical. It also offers a powerful tool for public health officials to track the spread of resistant strains and respond more effectively to outbreaks. The research team is now working to scale the technology for clinical use and is seeking regulatory approval. If successful, the system could become a standard part of infection management, helping to preserve the effectiveness of existing antibiotics and save thousands of lives each year.